Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $-5.69M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Actinium Pharmaceuticals USD -5.69M 1.81M Sep/2025
Amgen USD 3.96B 464M Dec/2025
Bioline Rx USD -2.21M 96K Sep/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025